Benign prostate hyperplasia
Conditions
Interventions
Group A:Control
Group B:Finasteride (5mg, oral administration, 6 months)
Group D:No smoking
Group E :Smoking
Sponsors
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Eligibility
Sex/Gender
Male
Age
55 Years to 89 Years
Inclusion criteria
Inclusion criteria: The inclusion criteria included patients who has lower urinary tract symptoms (LUTS) and obstruction due to BPH and requires indications for the surgical treatment of BPH.
Exclusion criteria
Exclusion criteria: Patients with renal function impairment (blood creatinine >145 umol/L); patients with impaired cardiopulmonary function; patients with an alteration of coagulation parameters [international normalised ratio (INR) >1.3] or any kind of bleeding disorders; patients that, in the past, had already undergone any kind of prostate surgery; patients that had already assumed a different scheme, period or dosage of any kind of 5-ARI; refusal to sign the informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Case history;Operation characters;Observation of perioperative period;Post-operation follow-up;Ultrasound of prostatic bloodstream;Preoperative Examination; | — |
Countries
China
Contacts
Public ContactZhong Wang
Outcome results
None listed